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Tax protein of human T-cell leukemia virus type 1 (HTLV-1) is a potent trans-activator of specific sets of target genes, and
on the other hand, it is a trans-repressor of other sets of genes. It is also an inhibitor of the tumor suppressor protein p16INK4a
and thus has been thought to contribute to induction of adult T-cell leukemia (ATL). We examined the mutagenic effects of
Tax on a cellular gene, hypoxanthine guanine phosphoribosyltransferase (hprt), and LacI gene in lambda shuttle vector
exogenously integrated in Big Blue Rat-2 (BBRat-2) cells. Expression of Tax in BBRat-2 cells enhanced the frequency of
HPRT(2) phenotype severalfold. Tax-expressing cell clones, BBTax-1 and -2 established from BBRat-2 cells, gave rise to an
average mutation frequency of 5.9 3 1025 in LacI gene, but Tax-negative cell clones, BBRat-C1 and -C2, showed 2.1 3 1025.
The 2.8-fold increase in mutation frequency in the presence of Tax indicates that Tax expression enhanced mutation
frequency in chromosomal DNA. However, neither the mutation spectrum of base transitions, transversions, and deletions/
insertions nor the loci of the mutations were significantly affected by Tax expression. These findings indicate that Tax has
the capability to induce random mutations and suggest that Tax would be able to modulate cellular phenotypes through
mutation of the cellular genome. © 1999 Academic Press
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Tumorigenesis is known to be triggered by chemical
arcinogens, radiation, ultraviolet light, and viral infec-
ion. Irrespective of the triggers, it is widely accepted that
umor formation progresses through multiple processes,
ost of which consist of a mutation followed by clonal
election of the mutated cells. Tumor cells consequently
ccumulate a number of mutations in various onco-
enes, tumor suppressor genes, and related genes
Land et al., 1983; Weinberg, 1989). Genes involved in
umorigenesis generally play critical roles in normal reg-
lation of cell proliferation, differentiation, apoptosis, and
mmunological responses, and thus, their abnormalities
lter basic cellular phenotypes. Whatever the triggers,
utations of these genes are critical events in tumor
rogression.
Adult T-cell leukemia (ATL) is a unique malignancy of
D4-positive T cells (Uchiyama et al., 1977; Hattori et al.,
981), associated with infection by human T-cell leuke-
ia virus type 1 (HTLV-1) (Poiesz et al., 1980; Hinuma et
l., 1981; Yoshida et al., 1982). Its causal effect was
roposed by analysis of the sites of provirus integration
Yoshida et al., 1984): In almost all cases, the leukemic
ells of ATL patients are infected with HTLV-1, integrating
ne or a few proviruses into the cellular DNA. The sites
1 To whom reprint requests and correspondence should be ad-
nressed: Fax: 81–3–5449–5421. E-mail: myoshi@ims.u-tokyo.ac.jp.
155f integration are not restricted to any specific loci when
ompared among ATL patients (Seiki et al., 1984); there-
ore, a trans-acting function of the viral product was
roposed to play a role in induction of ATL. Consistent
ith this prediction, tax gene, a unique gene in the pX
egion of HTLV-1 (Seiki et al., 1983), was identified to
unction in trans (Sodroski et al., 1984; Chen et al., 1985;
elber et al., 1985; Seiki et al., 1985). Furthermore, it was
hown to immortalize human T cells (Grassman et al.,
989), to transform rodent fibroblasts in cooperation with
as oncogene (Pozzati et al., 1990; Tanaka et al., 1990),
nd to induce tumors in its transgenic mice (Nerenberg
t al., 1987; Hinrichs et al., 1987). Because of these in
itro and in vivo observations, Tax has been proposed to
lay crucial roles in induction and/or progression of ATL.
Tax protein has been characterized as a trans-activa-
or of specific transcription (Sodroski et al., 1984; Fuji-
awa et al., 1985; Yoshida and Seiki, 1987), enhancing
he expression of some nuclear oncogenes (Fujii et al.,
988, 1991) and lymphokines and lymphokine receptors
Inoue et al., 1986; Yoshida et al., 1987). It also trans-
epresses transcription of a tumor suppressor gene,
F-1 (Feigenbaum et al., 1996), and DNA polymerase b
Jeang et al., 1990). Furthermore, Tax is shown to be an
ffective inhibitor of the tumor suppressor protein
16INK4a (Suzuki et al., 1996), which is a cell cycle inhib-
tor (Serrano et al., 1993). These effects of Tax on cellular
egulatory systems have been proposed as the mecha-
isms of immortalization of HTLV-1-infected T cells.
0042-6822/99 $30.00
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156 MIYAKE ET AL.Proliferation of infected T cells promoted by Tax would
e expected to result in a random population of infected
D4-positive T cells, since HTLV-1 infection and its ex-
ression have no particular specificity in CD41 cells. In
act, polyclonal expansion of the infected cell population
as demonstrated in carriers of HTLV-1 (Yoshida et al.,
984). After a long latency of 40 to 60 years, clonal
xpansion of a single infected T cell is triggered toward
eukemogenic progression. In understanding this event,
e were interested in the possible roles of mutations
hat might be associated with viral function. Supporting
his issue, Tax was shown to downregulate transcription
f DNA polymerase b (Jeang et al., 1990), which is es-
ential for the repair of damaged DNA. This finding
uggested a higher mutation frequency in HTLV-1-in-
ected cells; however, a mutagenic property of Tax pro-
ein has never been described.
In this work, we examined the mutagenic effects of Tax
n a cellular gene, hypoxanthine guanine phosphoribo-
yltransferase (hprt), and LacI gene exogenously inte-
rated in rat fibroblasts. The assays used analyzed re-
istance of cells to 6-mercaptopurine (Mehta et al., 1977)
nd blue plaques of lambda shuttle vector whose phe-
otype is controlled by the LacI gene (Wyborski et al.,
995). The results revealed that Tax expression en-
anced mutation frequency by a fewfold when compared
ith that in the absence of Tax expression. Sequence
nalysis of the mutated LacI genes, however, revealed
o significant alteration of mutation spectrum and loci.
hese observations indicate that Tax protein has the
apacity to induce random mutations, and its mutagenic
ffect might contribute to acceleration of transformation
f HTLV-1-infected T cells.
RESULTS
utation frequency in hprt gene
Mutations that inactivate the enzyme activity of hypo-
anthine guanine phosphoribosyltransferase (HPRT) are
asily detected by the appearance of cells resistant to
-MP (Mehta et al., 1977). 6-MP is converted into the
orresponding nucleotide by HPRT and then incorpo-
ated into DNA, replacing guanine residues to exert its
ytotoxic effect. The HPRT(2) cells cannot use 6-MP, and
hus the mutated cells become resistant to the drug. We
sed this system to examine the possible mutagenic
ffect of Tax.
BBRat-2 cells, a rat embryonic fibroblast line carrying
hagemid shuttle vector (Wyborski et al., 1995), were
ransfected with a mixture of pCG-Tax and pHyg, plas-
ids expressing Tax and hygromycine-resistance gene
hyg), respectively. The ratio of pCG-Tax to pHyg was
9:1; therefore, the vast majority of hygromycine-resistant
olonies were expected to carry the tax gene. Cells
xpressing the hygromycine-resistance gene were se-ected in the presence of hygromycine. Colonies in sev- dral plates were pooled 2 weeks after transfection, and
ignificant expression of Tax was confirmed by Western
lot analysis (data not shown). These cells were used as
ax-expressing BBRat-2 cells. Cells without tax gene as
ontrol were isolated similarly by transfection of the
mpty vector and pHyg.
The Tax-expressing cell population was then exposed to
-MP at 5 mg/ml for 2 weeks. After fixation and staining of
he cells, colonies consisting of more than 50 cells were
ounted as 6-MP-resistant cells. The frequency of colonies
f Tax-expressing cells was 3 3 1025 and was 3-fold higher
han that of control cells that did not express Tax (Exp† 1 in
able 1). The plating efficiencies of both cell types were
onitored for determination of the effective cell numbers for
olony formation. Another assay performed under similar
onditions gave a frequency of 5.9 3 1025, which was
.8-fold higher than that of the control cells (Exp† 2 in Table
). Although the values somewhat deviated in these two
ssays and the numbers were too small for statistical anal-
sis, the frequency of resistant colonies in the presence of
ax was significantly higher than that in its absence. On
verage, the mutation frequency of Tax-expressing cells
as 4.5 3 1025 and was 5.6-fold higher than that in the
resence of Tax expression.
To exclude the possibility that these results may reflect
lteration of the drug sensitivity of the cells, the acute
ytotoxicity of 6-MP to Tax-expressing cells was examined;
ax-expressing and nonexpressing cells were treated with
arious concentrations of the drug for 3 days and the viable
ells were then assayed by MTT. No significant difference
as observed between these two types of cells (Fig. 1).
rowth properties up to 4 days were not altered by the
xpression of Tax (data not shown). Therefore, the differ-
nces observed in 6-MP resistance between Tax-positive
nd -negative cells were attributed to the mutagenic effect
f Tax on the cellular gene hprt.
utation frequency in LacI gene integrated in
BRat-2 cells
The mutagenic effect of Tax was suggested by its
ncreasing effect on resistance to 6-MP, although these
esults rather fluctuated. To confirm the mutagenic effect
f Tax, we used another system with Big Blue (BB) Rat-2
ells, a Rat2 cell line carrying 40–50 copies of phagemid
huttle vector that contains a set of the LacI and aLacZ
enes (Wyborski et al., 1995). The shuttle vector is easily
ackaged into phages just by incubating the cellular
NA with the packaging extracts, and the reconstructed
hages can be examined with the standard procedure
or the plaque assay. When the LacI gene in the vector is
nactivated by any mutation, the aLacZ gene in the same
ector is expressed and the plaques are visualized as
lue in the presence of X-Gal. Otherwise, the plaques
emain white. Accordingly, a huge number of indepen-
ent LacI genes in cells can be assayed for mutations,
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157HTLV-1 Tax ENHANCES MUTATIONnd the isolated LacI gene in each phage can be se-
uenced without any further amplification by polymerase
hain reaction.
To examine any mutagenic effect of Tax using this
ystem, pCG-Tax was transfected into BBRat-2 and the
table transformants of Tax were isolated (Tax series of
ell clones). As a control, the vector was transfected and
imilarly processed (C series of cell clones). Two typical
ell clones, BBTax-1 and -2, were confirmed to express
ax at significant levels as shown in Fig. 2A. The levels
f Tax protein in these cell clones were similar to those
n HTLV-1-infected T-cell lines. Furthermore, Tax protein
xpressed in these cell clones was confirmed to be
ctive as a trans-activator of specific transcription as
ollows (Fig. 2B): When a reporter plasmid with Tax-
esponsive enhancer, p21bp-Luc, was transfected into
BTax-1 or -2 cells, luciferase activity was more than
0-fold higher than that with a reporter without Tax-
esponsive enhancer. Furthermore, p21bp-Luc did not
ive rise to an increase in luciferase activity in BBRat-C1
nd -C2 cells, which did not carry tax gene.
Following the passages of these cell clones for 4 to 6
eeks, the cellular DNA was extracted and the DNA was
sed for packaging into phages. The phages thus res-
ued were assayed for mutations in the presence of
-Gal. The frequency of blue plaques was estimated for
ach of the Tax-expressing cell clones, BBTax-1 and
BTax-2, and also for Tax-negative cell clones, BBRat-C1
nd BBRat-C2. The assay was repeated several times by
ackaging the same DNA preparation from each cell
lone. After screening 1.7 to 4.8 3 105 phage plaques
rom each cell clone, the average frequency of blue
laques was 6.7 3 1025 and 5.1 3 1025 for BBTax-1 and
BTax-2 cells, and 2.1 3 1025 for both BBRat-C1 and
BRat-C2 cells (Table 2). The frequency of blue plaques
as reproducible among experiments with each cell
lone, and the average frequency was also reproducible
n two independent cell clones of each cell type. Average
requency of blue plaques was 5.9 3 105 and 2.1 3 105
or Tax-positive and -negative cells, respectively. A 2.8-
old higher frequency was observed in the presence of
ax expression than in its absence. Statistical analysis of
T
Frequency of 6-MP-Resistant Colonies of BBRat-2
Exp†
1Tax
Resistant colonies/total cells Mutation frequency
1 25/8.3 3 105 3.0
2 44/7.4 5.9
verage 4.5
Note. Random cell clones of BBRat-2 with or without Tax expressio
ontaining more than 50 cells were counted as 6-MP-resistant coloniehese data confirmed the significance of the 2.8-fold mncrease at P , 0.01. Two independent cell clones gave
rincipally the same results (Table 2); therefore, the ob-
ervations obtained here were not due to a single ab-
ormal cell clone.
equencing of mutated LacI genes
To investigate the spectrum of mutations in the LacI
ene, the phagemid was generated as a plasmid and the
ntire region of the LacI gene covering 1083 bp was
equenced using appropriate primers. Fifty mutations
ere found in 47 blue plaques from BBTax-1 and -2 cells,
nd 15 mutations from BBRat-C1 and -C2 cells, all of
hich had at least one mutation inducing amino acid
lteration, termination, or frame shift of translation. Thus,
he reliability of the blue plaque assay has been verified.
The sites of spontaneous mutations were somewhat
ocalized in the 59 region of LacI (Table 3) as described
reviously (Zimmer et al., 1996), and this pattern was not
ffected by expression of Tax; 32 of 50 mutations in
BTax-1 and -2 cells and 12 of 15 in BBRat-C1 and -C2
ells were found in the first 360 bp of the LacI gene. The
utation spectra in the presence and absence of Tax
xpression were not distinct from each other as summa-
ized in Table 4: The frequency of base transition, G:C Ý
:T, was 42 and 47% in the series of BBTax and BBRat-C
ells, respectively, and that of A:T Ý G:C transition was
and 0%, respectively. Frequency of base transversion,
:C Ý T:A, was 22 and 13%, and thus was not signifi-
antly different between the series of BBTax and BBRat-C
ells. The frequencies of other mutations were too small
or quantitative comparison (Table 4). Taken together, it
an be concluded that Tax enhanced the mutation fre-
uency, but the enhancement was not restricted to a
articular type of mutation or to a specific site of the LacI
ene.
DISCUSSION
In this study we demonstrated the mutagenic effect of
TLV-1 Tax on cellular chromosomal DNA. Although it
as been proposed previously (Jeang et al., 1990; Mjone
t al., 1993), this effect has never been reported. The
in the Presence and Absence of Tax Expression
2Tax
Resistant colonies/total cells Mutation frequency 3 1025
5/5.2 3 105 1.0
4/6.6 0.6
0.8
cultured in the presence of 5 mg/ml 6-MP for 14 days and coloniesABLE 1
Cells
3 1025
n wereutagenic effect was demonstrated in two independent
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158 MIYAKE ET AL.ystems using BBRat-2 cells, induction of HPRT(2) phe-
otype assayed by 6-MP-resistance (Mehta et al., 1977)
nd LacI(2) phenotype assayed by blue plaque formation
ollowed by sequence analysis (Wyborski et al., 1995).
he former is an endogenous gene expressed in cells,
nd the latter system, the LacI gene of E. coli exog-
nously integrated in Rat-2 cells. The assays for the
utations were carried out 4 to 6 weeks after the initial
xpression of Tax.
The mutation frequency observed in the LacI gene
as enhanced about threefold by Tax; however, the mu-
ation spectrum in the LacI gene was not significantly
ffected by Tax expression and was very similar to that of
pontaneous mutations. These observations imply that
ax may have induced mutations through modification of
he general machinery involved in repair of damaged
NA or through reduction of the fidelity of DNA synthe-
is. Downregulation of DNA polymerase b by Tax expres-
ion (Jeang et al., 1990) could be one of the mechanisms,
ince it plays a critical role in repair of mismatched DNA
hrough base-excision repair activity. Alternatively, the
ffect of Tax on the G2/M checkpoint protein, TaxBP-1
Jin et al., 1998), could be an attractive mechanism to
xplain the results observed in this study.
The threefold increase in the mutation frequency by
ax expression was statistically significant, although this
ounds like a rather small effect. The cell type used in
hese studies was a rodent fibroblastic line, different
rom T cells, which are the target of HTLV-1 infection and
ransformation. Therefore, one may argue a difficulty in
pplying these data to human T cells. However, as far as
he mutagenic capacity of Tax protein is concerned, the
bservations should be significant. In our system, expo-
ure of cells to 20 J/m2, which is one-third the lethal dose,
nduced a 10- to 15-fold higher mutation frequency at
acI loci over untreated cells (data not shown). UV light
FIG. 1. Sensitivity of BBTax-1 and BBRat-2 cells to the cytotoxic
ffects of 6-MP. BBTax-1 and BBRat-2 cells were culturred in the
resence of various concentration of 6-MP for 3 days and viable cells
ere estimated by MTT assay. Closed squares and open circles rep-
esent viable cell fraction of Rat-2 cells with and without Tax expres-
ion, respectively.ith 1–7 J/m2 is described to be the effective dose for rransformation of mouse fibroblasts (Little, 1979); thus,
hese preliminary observations on UV light suggest that
he threefold increase in mutation frequency observed
or Tax protein would be significant for the biological
ffects.
The effect of Tax on mutation frequency might also
ave significance with respect to transformation or tu-
origenesis. Treating BBRat-2 cells with 1 mg/ml 7,12-
imethylbenz[a]anthracene (DMBA) for 24 h or 100 mg/ml
thylnitrosourea (ENU) for 30 min induced a 3- to 7-fold
ncrease in mutation frequency in the LacI gene (Man-
anatha et al., 1996; Zimmer et al., 1996). A similar fold
ncrease in mutation frequency by infection of a trans-
orming virus was also described for hprt gene: Infection
FIG. 2. Characterization of BBTax-1 and -2 cells expressing Tax
rotein. (A) Tax expression in stable transformants, BBTax-1 and -2,
stablished from BBRat-2 carrying the phagemid with aLacZ and LacI
enes. Total cell extracts were subjected to Western blot analysis using
nti-Tax antibodies. MT-2 is an HTLV-1-infected human T-cell line ex-
ressing Tax. (B) Trans-activating capacities of Tax protein expressed
n BBTax-1 and -2 cells. Reporter with (21-bp 3 5) or without (none) the
ive repeats of the Tax-responsive 21-bp enhancer was transfected into
ells and the luciferase activity expressed was estimated. The luc
ctivity was expressed as a ratio to the enhancerless promoter in each
ell clone. BBRat-C1 is a control cell clone without tax gene, and
ransfected with pCGTax, a Tax-expressing plasmid (1Tax) as a posi-
ive control for Tax-mediated activation. dN in the reporter construct
epresents the promoter sequence of the HTLV-1 long terminal repeat.
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159HTLV-1 Tax ENHANCES MUTATIONf a rat cell line, XC cells, with herpes simplex virus type
(HSV-2) increased mutation frequency by a factor of 2.5
o 10 depending on the multiplicity of infection (Pilon et
l., 1985). Furthermore, injection of 4.5 mg/kg ENU into
ig Blue (BB) mice induced a 5-fold increase in mutation
requency at hprt and a 1.5-fold increase at LacI in T cells
n vivo (Skopek et al., 1995). These documents imply that
hese severalfold increases in mutation frequency in hprt
nd LacI genes are biologically significant, therefore
uggesting a 3-fold increase in our system would also
ave significance. Accordingly, it is possible to speculate
hat Tax increases the incidence of ATL by increasing the
utation frequency in a certain target gene, in addition to
nducing abnormal cell proliferation through multiple
echanisms such as trans-activation or trans-repression
f transcription and inhibition of tumor suppressor pro-
eins (Yoshida et al., 1993).
MATERIALS AND METHODS
ells, plasmids, and antibodies
HTLV-1-infected T-cell lines were maintained in RPMI
640 with 10% fetal calf serum. Big Blue rat cell line
BBRat-2), a Rat2 fibroblastic line carrying the phagemid
ith aLacZ and LacI genes, was obtained from Strat-
gene (Wyborski et al., 1995), and was maintained in
TABLE 2
Mutation Frequency Observed in LacI Gene by Blue Plaque Assay
Cella Exp† Blue plaques Total plaques Mutation frequency
BTax-1 1 6 83.7 3 1023 7.2 3 1025
2 6 87.1 6.8
3 5 62.0 8.1
4 5 128 3.9
5 4 51.4 7.9
6 4 66.1 6.1
verage 6.7 6 1.5
BTax-2 1 6 87.9 6.8
2 4 65.3 6.1
3 4 79.9 5.0
4 3 119 2.5
verage 5.1 6 1.9
BRat-C1 1 2 118 1.7
2 2 115 1.7
3 4 109 3.7
4 2 135 1.5
verage 2.1 6 1.0
BRat-C2 1 3 93.2 3.2
2 2 179 1.1
verage 2.1 6 1.5
a BBTax-1 and BBTax-2 cells were cultured for 4 to 6 weeks after
xpression of Tax. Control cell clones, BBRat-C1 and BBRat-C2, were
imilarly processed in parallel.ulbecco’s modified Eagle’s medium (DMEM) supple-ented with 10% fetal calf serum according to the man-
facturer’s protocol. Cells grown in the initial culture
ere frozen and the revived cells were used within about
month to avoid unexpected alterations of the pheno-
ypes and genotypes.
Tax expression vector, pCG-Tax (Fujisawa et al., 1989),
nd reporter plasmids with or without Tax-responsive
nhancer, p21bp-Luc and dN55-Luc (Fujisawa et al.,
TABLE 3
Mutations in LacI Gene Accumulated in the Presence
and Absence of Tax Expression
Position
BBTax-1 and -2 BBRat-C1 and -C2
Mutation Remark Mutation Remark
28 G Ý A 32 CpG
47 C Ý T
59 T Ý A
65 G Ý T
G Ý C 32 CpG
67 G Ý T CpG
72 C Ý del
74 A Ý T
111 A Ý del A Ý del
130 G Ý T CpG
139 T Ý G
140 A Ý G
145 C Ý T 32
146 C Ý A
C Ý T
150 C Ý A
157 G Ý A 34
G Ý T G Ý T
64–166 del
170 C Ý T CpG
171 G Ý del
242 C Ý A CpG C Ý T CpG
245 C Ý A CpG
265 C Ý T
288 G Ý del
301 C Ý T 33 CpG C Ý T CpG
329 C Ý A CpG
332 T Ý A
336 C Ý del
353 G Ý A 32 CpG
355 G Ý del CpG
439 T Ý ins 32
490 G Ý T
560 G Ý A
G Ý del 33
01–604 del
602 G Ý A
612 T Ý del
625 C Ý T 33
815 G Ý A
889 G Ý A
C Ý C
898 A Ý C
931 C Ý T
933 G Ý T 32
983 C Ý T
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160 MIYAKE ET AL.989), were previously described. A pHyg carrying hy-
romycine (hyg)-resistance gene was constructed by in-
erting the hyg sequence downstream of the promoter of
he thymidine kinase gene. Antiserum against Tax was
aised against the C-terminus peptide as described pre-
iously (Kiyokawa et al., 1984).
solation of stable transformants of Tax
The plasmid mixture of pCG-Tax (9.5 mg) and pHyg (0.5
g) was transfected into BBRat-2 by the calcium phos-
hate procedure as previously described (Fujisawa et
l., 1989) and cultured in the presence of 200 mg/ml
ygromycine. After 2 weeks, colonies in several plates
ere pooled, cultured in the presence of hygromycine,
nd then used for assays of sensitivity and resistance to
-mercatopurine (Mehta et al., 1977). Control cells were
imilarly isolated after transfection of the empty vector
nd pHyg.
For isolation of stable clones expressing Tax, BBRat-2
ells were similarly processed as described above for 2
eeks, and then independent colonies were isolated
sing a cloning cylinder. Among several clones isolated,
wo independent cell clones, BBTax-1 and -2, were used
or the mutation assay. As controls, an empty vector was
ransfected and the cells were similarly processed, es-
ablishing BBRat-C1 and -C2 cell clones. The isolated
ell clones were used as Tax-negative cells for the con-
rol in the mutation assay.
ssays for sensitivity and resistance to
-mercaptopurine
To assay the proportion of cells resistant to 6-MP, 1 3
05 each of Tax-expressing random cell clones and non-
xpressing cell clones were plated into ten 100-mm
lates and treated with 5 mg/ml 6-mercaptopurine (6-
TABLE 4
Mutation Spectra in the Presence and Absence of Tax Protein
Type of mutation
Number (%) of mutations
BBTax-1 BBRat-2
ransitions
G:C Ý A:T 21(42) 8(16)a 7(47) 2(13)a
A:T Ý G:C 1(2) 0
ransversions
G:C Ý T:A 11(22) 5(10)a 2(13) 1(7)a
G:C Ý C:G 3(6) 2(4)a 0
A:T Ý C:G 2(4) 0
A:T Ý T:A 2(4) 1(7)
eletion and insertion 10(2) 5(33)
otal mutations 50(100) 15(100)
a At CpG.P); every 3 days, the cells were fed with fresh mediumontaining the same concentration of the drug. Cells in
he plate were fixed on Day 14 by treatment with 1%
lutaraldehyde, stained with Giemsa reagent, and
cored for the colonies containing more than 50 cells. In
arallel, plating efficiency of both cell types was moni-
ored for determination of the cell numbers effective for
olony formation.
The cytotoxic effect of 6-MP was examined as follows
ccording to Mehta and Hutchison (Mehta et al., 1977):
ells (1 3 103) were plated in a 96-well plate and, the
ext day, were treated with various concentrations of
-MP for the following 3 days. Viable cells were esti-
ated with the MTT assay kit according to the manufac-
urer’s protocol (Boehringer-Mannheim, Mannheim, Ger-
any).
n vitro packaging of phages and plaque assay
High-molecular-weight cellular DNA was prepared
rom the samples of BBTax-1, BBTax-2, BBRat-C1, and
BRat-C2 cells, and the DNA (4 mg) was incubated in the
ackaging solution supplied by the manufacturer (Strat-
gene) for 180 min at 30°. To the mixture, a suspension
f the Escherichia coli strain SCS-8 (recA2sup0) in the
rowing state was added and plated on top of the aga-
ose plate containing X-Gal (5-bromo-4-chloro-3-indolyl-
-D-galactoside) at a concentration of 1.5 mg/ml. After
ncubation overnight, white and blue plaques were
ounted and the frequency of blue color was used as the
utation frequency of LacI gene under the given condi-
ions. Differences between mutation frequencies in the
resence and absence of Tax were tested for statistical
ignificance by Student’s t test. The mutation frequency
s expressed as the mean 6 standard deviation of the
ean.
equence analysis of LacI gene
E. coli were infected with phages from blue plaques
ogether with the helper phage according to the manu-
acturer’s protocol (Stratagene), to convert the LacI target
ene into a plasmid. From each colony thus formed,
lasmid DNA containing the LacI gene was isolated and
equenced directly by the dideoxy termination method
s previously described (Saito et al., 1995).
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